This week from Drug Target Review...
EDITOR'S PICK
Researchers in the US have developed a potential HIV vaccine approach that aims to prompt the creation of broadly neutralising antibodies via mRNA.
TOP STORIES THIS WEEK
The Scripps Research team showed that a variation of an already FDA-approved therapeutic for neurological disease can block COVID-19 infection in animals.
Victoria Rees and Ria Kakkad from?Drug Target Review?bring you the key takeaways from the ELRIG Drug Discovery 2022 event in London.
The new LSD-like compounds activated the 5HT2a receptor, a receptor stimulated by serotonin, without causing hallucinations.
Deleting the gene?POU2AF2?kills cancer cells in deadly subtype of small-cell lung cancer.
AMAZON RAINFOREST. ONE RESPONSE. ONE TREE ??
Did you know that tree planting is recognised as one of the most engaging, environmentally friendly activities that people can take part in to better the planet?
?Here at Drug Target Review, we want to do our part for reforestation and would love for you to get on board with us!
?All we need is 3 minutes of your time to fill in our biopharma tech survey. For every fully completed survey, a tree will be planted in the Amazon Rainforest as a thank you.
?About the survey
?As novel technologies continue to filter into disease research and drug discovery processes, we want to know which platforms you utilise most and why. Start survey here>>>
领英推荐
A thought for you…
?With the world's largest rainforest ecosystem, the Amazon Rainforest spans 9 countries and is home to iconic species like the jaguar, black spider monkey and poison dart frog. By holding an estimated 90-140 billion metric tons of carbon, its forests play a critical role in the fight against climate change. Think of the difference you can make by simply sharing your feedback!
Survey closes Friday 28 October and responses are completely anonymous.
WHAT TO WATCH
Ranging from decoding cancer inflammation to engineering cell lines and everything in between - discover our range of upcoming?live webinars and on-demand sessions?which are completely?FREE?to join.
WHAT TO LISTEN TO
Tune in to hear our experts discuss the advantages of multiplexed imaging for a wide range of research and how this technique will develop in the future.
JOIN THE COMMUNITY
Sign up to our?FREE?journal?for information on the drug discovery industry; promoting the latest research and developments, funding projects, and cutting-edge technological developments, as well as access to: